- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease Moderate in Brazil
Total 1092 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
University of Sao PauloCompletedQuality of Life | Dyspnea | Respiratory SymptomsBrazil
-
Universidade Estadual de LondrinaUnknownChronic Obstructive Pulmonary Disease | Idiopathic Pulmonary Fibrosis | Asthma ChronicBrazil
-
Hospital Nossa Senhora da ConceicaoCompletedChronic Obstructive Pulmonary Disease | Weaning of Mechanical VentilationBrazil
-
Federal University of São PauloCompletedPulmonary Disease, Chronic Obstructive | Pulmonary Emphysema | Chronic BronchitisBrazil
-
Universidade Estadual de LondrinaNational Council for Scientific and Technological Development (CNPq) - BrazilUnknownPulmonary Disease, Chronic ObstructiveBrazil
-
Universidade Federal de PernambucoCompletedPulmonary Disease, Chronic ObstructiveBrazil
-
Hospital de Clinicas de Porto AlegreCompletedPulmonary Disease, Chronic Obstructive | Rehabilitation | Dietary SupplementsBrazil
-
Federal University of UberlandiaCompletedPulmonary Disease, Chronic ObstructiveBrazil
-
Universidade Estadual de LondrinaKU LeuvenUnknownPulmonary Disease, Chronic ObstructiveBelgium, Brazil
-
University of the State of Santa CatarinaTerminatedPulmonary Disease, Chronic ObstructiveBrazil
-
Associação Fundo de Incentivo à PesquisaFederal University of São PauloTerminatedObstructive Sleep Apnea Syndrome | Chronic Obstructive Pulmonary DiseaseBrazil
-
Pulmair Medical, Inc.Active, not recruitingPulmonary Disease, Chronic Obstructive | EmphysemaNetherlands, Germany, Brazil
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)France, Germany, United Kingdom, United States, Australia, Austria, Brazil, Hungary, New Zealand, Romania, Russian Federation
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseArgentina, Dominican Republic, Panama, Mexico, Brazil, Chile, Ecuador, Honduras
-
Universidade Metodista de PiracicabaCompletedRehabilitation Cardiorrespiratory Improvement in Patients With Chronic Disease Obstructive PulmonaryChronic Disease Obstructive PulmonaryBrazil
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Netherlands, Belgium, Denmark, Germany, United Kingdom, Brazil
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, United Kingdom, China, Philippines, Italy, Taiwan, Puerto Rico, Israel, Thailand, Peru, Colombia, Poland, Brazil, Germany, Russian Federation, Romania, France, Chile, Greece
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil, United Kingdom, Germany, Philippines, Denmark, Australia, Argentina, India, Belgium
-
University of Sao PauloCompletedChronic Pulmonary Obstructive DiseaseBrazil
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Canada, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, United States, Denmark, Italy, Canada, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, India, Japan, Vietnam, Malaysia, Thailand, Korea, Republic of, Mexico, Brazil, Greece, Poland, France, Peru, Chil... and more
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, China, Spain, Italy, Belgium, Korea, Republic of, Poland, Taiwan, Israel, United Kingdom, Japan, Czechia, New Zealand, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, France, India, Canada, ... and more
-
Hospital de Clinicas de Porto AlegreMinistry of Health, Brazil; Conselho Nacional de Desenvolvimento Científico... and other collaboratorsCompleted
-
University of the State of Santa CatarinaFederal University of Health Science of Porto AlegreCompletedPulmonary Disease, Chronic ObstructiveBrazil
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Austria, Belgium, Germany, Greece, Russian Federation, Australia, Brazil, Canada, Denmark, France, Hungary, Israel, Italy, Netherlands, Poland, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary DiseaseUnited States, Austria, Canada, Denmark, Germany, Italy, Spain, United Kingdom, Belgium, Vietnam, Brazil, Hungary, Philippines, China, Korea, Republic of, Argentina, Australia, Poland, Turkey, Japan, Greece, Netherlands, Czechia, Mexico, Bulgar... and more
-
Hospital de Clinicas de Porto AlegreAssociação Fundo de Incentivo à PesquisaCompletedPulmonary Disease, Chronic ObstructiveBrazil
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, France, Italy, Spain, Turkey, United Kingdom, Germany, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Greece, Ireland, Switzerland
-
Butantan InstituteNot yet recruitingCardiovascular Diseases | COVID-19 | Diabetes Mellitus | Cancer | Chronic Obstructive Pulmonary Disease | Chemotherapy | Immunosuppression | Renal Disease | Other Complication of Kidney TransplantBrazil
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of, Turkey, United States, Chile, Czechia, Israel, Russian Federation, Argentina, Brazil, Bulgaria, Canada, Denmark, Estonia, France, Georgia, Germany, Hungary, India, Japan, Latvia, Lithuania, Mexico, Netherlands, Norway and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveBrazil
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Spain, Chile, Germany, Korea, Republic of, Bulgaria, Brazil, Slovakia
-
SanofiRegeneron PharmaceuticalsActive, not recruitingChronic Obstructive Pulmonary DiseaseGreece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Peru, South Africa, Argentina, Mexico, Brazil, Chile, Colombia, Venezuela
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Colombia, Romania, South Africa, Italy, Hungary, Taiwan, Turkey, Switzerland, Australia, France, Israel, Sweden, China, Thailand, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Argentina, Lithuania, Austria, Cana... and more
-
Queen's UniversityKU Leuven; Federal University of Rio Grande do Sul; Federal University of São...UnknownPulmonary Disease, Chronic Obstructive | Heart Failure, SystolicBelgium, Brazil
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Costa Rica, Brazil, Chile, Mexico, Argentina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Russian Federation, Ukraine, United States, South Africa, Korea, Republic of, Romania, Canada, France, Italy, Chile, Denmark
-
Pulmonx CorporationCompletedEmphysemaUnited States, Netherlands, United Kingdom, Brazil
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Croatia, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, South Africa, Spain, Sweden, Thailand, Ukraine
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructivePuerto Rico, United States, Australia, Argentina, France, Germany, Japan, Netherlands, Russian Federation, Spain, Ukraine, Finland, Czechia, Poland, Belgium, Chile, Peru, South Africa, Sweden, Thailand, Israel, Korea, Republic of, C... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, Romania, Russian Federation, South Africa, Spain, Sweden, Thailand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
PfizerTerminatedDiabetes Mellitus | Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Brazil, Costa Rica, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Belgium, Brazil, Bulgaria, China, Denmark, France, Germany, Greece, Hungary, Italy, Netherlands, New Zealand, Philippines, Poland, Russian Federation, South Africa, Spain, Taiwan, Tunisia, Turkey, Ukraine, United Kingdom
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease | Asthma | COPDUnited States, Canada, Germany, Italy, Spain, United Kingdom, Mexico, Australia, Argentina, France, China, Japan, Brazil, Korea, Republic of, Colombia, Denmark, Netherlands, Norway, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Brazil, Canada, China, Colombia, Croatia, Germany, Hungary, India, Ireland, Japan, Norway, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom